Connect your AI

Precigen PGEN Investment Purchases

Investment Purchases at other companies

Gilead SciencesGILD

$525M—

Viridian Therapeutics, Inc.VRDN

$91.32M+28.2%

Agios PharmaceuticalsAGIO

$148.18M-15.3%

Arrowhead ResearchARWR

$924.64M+43.5%

Ultragenyx PharmaceuticalRARE

$131M—

BridgeBio PharmaBBIO

$52.67M—

Other financials

Income statement

Revenue$23.3M+1,634%

Operating income-$6.0M+73.5%

Net income-$7.9M+85.4%

EPS (diluted)-$0.02+88.9%

Balance sheet

Cash & equivalents$7.5M+23.5%

Total debt$98.3M+1,714%

Total equity$20.2M+244%

Total assets$138.6M+7.6%

Cash flow

Operating cash flow-$43.8M-168%

CapEx$258.0K-58.5%

Free cash flow-$44.1M-160%

Valuation

Market cap$1.91B+213%

Enterprise value$2B+234%

P/S72×—

Profitability

Gross margin83.6%—

Operating margin-2,890.9%—

Net margin-3,656%—

FCF margin-1,756.5%—

Returns & leverage

Return on equity-843.6%-1,103pp

Debt / equity4.9×—

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Precigen's investment purchases?: Precigen (PGEN) reported investment purchases of $33.87M in Q1 2026.
How has Precigen's investment purchases changed year-over-year?: Precigen's investment purchases increased by 225.5% year-over-year, from $10.41M to $33.87M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.